NEPH (STOCKS)
Nephros Inc.
$2.910000
-0.070000 (-2.35%)
Prev close: $2.980000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Robert Banks
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $31.34M
- Employees
- 31
- P/E (TTM)
- 27.18
- P/B (TTM)
- 3.09
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
5
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$0.08 | $0.01 | +0.0698 | +684.31% |
|
Sep 2025 (Q3)
|
$0.03 | $-0.02 | +0.0504 | +247.06% |
|
Jun 2025 (Q2)
|
$0.02 | $-0.03 | +0.0455 | +178.43% |
|
Mar 2025 (Q1)
|
$0.05 | $-0.01 | +0.0551 | +1,080.39% |
Financial Statements
| Revenues | $18.79M |
| Benefits Costs and Expenses | $17.58M |
| Cost Of Revenue | $7.16M |
| Costs And Expenses | $17.58M |
| Gross Profit | $11.63M |
| Nonoperating Income/Loss | $60.00K |
| Operating Expenses | $10.48M |
| Selling, General, and Administrative Expenses | $9.00M |
| Depreciation and Amortization | $140.00K |
| Research and Development | $1.34M |
| Operating Income/Loss | $1.15M |
| Income/Loss From Continuing Operations After Tax | $1.19M |
| Income/Loss From Continuing Operations Before Tax | $1.21M |
| Income Tax Expense/Benefit | $12.00K |
| Income Tax Expense/Benefit, Current | $12.00K |
| Net Income/Loss | $1.19M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $1.19M |
| Net Income/Loss Available To Common Stockholders, Basic | $1.19M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $0.11 |
| Diluted Earnings Per Share | $0.11 |
| Basic Average Shares | 10,612,288 |
| Diluted Average Shares | 10,968,063 |
| Assets | $13.64M |
| Current Assets | $11.22M |
| Inventory | $3.23M |
| Other Current Assets | $7.99M |
| Noncurrent Assets | $2.42M |
| Fixed Assets | $106.00K |
| Other Non-current Assets | $2.31M |
| Liabilities | $3.44M |
| Current Liabilities | $2.77M |
| Accounts Payable | $914.00K |
| Other Current Liabilities | $1.85M |
| Noncurrent Liabilities | $672.00K |
| Equity | $10.20M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $10.20M |
| Liabilities And Equity | $13.64M |
| Net Cash Flow From Operating Activities | $1.65M |
| Net Cash Flow From Operating Activities, Continuing | $1.60M |
| Net Cash Flow From Investing Activities | -$1.64M |
| Net Cash Flow From Investing Activities, Continuing | -$1.60M |
| Net Cash Flow From Financing Activities | -$5.00K |
| Net Cash Flow From Financing Activities, Continuing | -$5.00K |
| Net Cash Flow | $0.00 |
| Net Cash Flow, Continuing | $0.00 |
| Comprehensive Income/Loss | $1.19M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $1.19M |
| Other Comprehensive Income/Loss | $0.00 |